X4 PharmaceuticalsXFOR
13F holders, Q1 2025 (March 31)2holders
$0.24avg. 13F price*
At the end of Q1 2025, 2 institutions reported holding X4 Pharmaceuticals Inc. (XFOR) in their 13F filings. The largest holders were T. Rowe Price Associates Inc. ($20K) and EverSource Wealth Advisors, LLC ($7).
- Company
- X4 Pharmaceuticals Inc.
- CUSIP
- 98420X202
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $20K |
| Exits | 0 | $0 |
Ownership 2 holders
| T. Rowe Price Associates Inc. | 0.00% | New | 83,015 | $20K |
| EverSource Wealth Advisors, LLC | 0.00% | New | 30 | $7 |
"% of holder's portfolio" is XFOR's weight in each manager's 13F, not the share of X4 Pharmaceuticals Inc. the manager owns.